Logo image of MELE.BR

MELEXIS NV (MELE.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:MELE - BE0165385973 - Common Stock

57.3 EUR
+0.45 (+0.79%)
Last: 12/30/2025, 7:00:00 PM
Fundamental Rating

6

MELE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 57 industry peers in the Semiconductors & Semiconductor Equipment industry. While MELE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MELE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

MELE had positive earnings in the past year.
In the past year MELE had a positive cash flow from operations.
MELE had positive earnings in each of the past 5 years.
MELE had a positive operating cash flow in each of the past 5 years.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

MELE has a better Return On Assets (14.20%) than 82.46% of its industry peers.
The Return On Equity of MELE (25.94%) is better than 75.44% of its industry peers.
MELE has a Return On Invested Capital of 15.69%. This is in the better half of the industry: MELE outperforms 78.95% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MELE is significantly above the industry average of 14.06%.
The last Return On Invested Capital (15.69%) for MELE is well below the 3 year average (31.03%), which needs to be investigated, but indicates that MELE had better years and this may not be a problem.
Industry RankSector Rank
ROA 14.2%
ROE 25.94%
ROIC 15.69%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

MELE's Profit Margin of 15.42% is in line compared to the rest of the industry. MELE outperforms 57.89% of its industry peers.
MELE's Profit Margin has improved in the last couple of years.
MELE has a Operating Margin (18.29%) which is in line with its industry peers.
MELE's Operating Margin has improved in the last couple of years.
The Gross Margin of MELE (40.24%) is worse than 64.91% of its industry peers.
In the last couple of years the Gross Margin of MELE has grown nicely.
Industry RankSector Rank
OM 18.29%
PM (TTM) 15.42%
GM 40.24%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

MELE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, MELE has about the same amount of shares outstanding.
Compared to 5 years ago, MELE has more shares outstanding
MELE has a worse debt/assets ratio than last year.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

MELE has an Altman-Z score of 6.17. This indicates that MELE is financially healthy and has little risk of bankruptcy at the moment.
MELE has a Altman-Z score (6.17) which is in line with its industry peers.
The Debt to FCF ratio of MELE is 3.48, which is a good value as it means it would take MELE, 3.48 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 3.48, MELE perfoms like the industry average, outperforming 43.86% of the companies in the same industry.
MELE has a Debt/Equity ratio of 0.62. This is a neutral value indicating MELE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.62, MELE is not doing good in the industry: 77.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 3.48
Altman-Z 6.17
ROIC/WACC1.43
WACC11.01%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 5.59 indicates that MELE has no problem at all paying its short term obligations.
MELE has a better Current ratio (5.59) than 91.23% of its industry peers.
A Quick Ratio of 2.71 indicates that MELE has no problem at all paying its short term obligations.
MELE has a better Quick ratio (2.71) than 80.70% of its industry peers.
Industry RankSector Rank
Current Ratio 5.59
Quick Ratio 2.71
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

MELE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.51%.
MELE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.04% yearly.
The Revenue for MELE has decreased by -16.57% in the past year. This is quite bad
The Revenue has been growing by 13.89% on average over the past years. This is quite good.
EPS 1Y (TTM)-46.51%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-46.03%
Revenue 1Y (TTM)-16.57%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-13.14%

3.2 Future

Based on estimates for the next years, MELE will show a small growth in Earnings Per Share. The EPS will grow by 7.41% on average per year.
MELE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.53% yearly.
EPS Next Y-29.28%
EPS Next 2Y-8.34%
EPS Next 3Y1.48%
EPS Next 5Y7.41%
Revenue Next Year-10.45%
Revenue Next 2Y-1.26%
Revenue Next 3Y2.16%
Revenue Next 5Y5.53%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.38, which indicates a rather expensive current valuation of MELE.
Compared to the rest of the industry, the Price/Earnings ratio of MELE indicates a rather cheap valuation: MELE is cheaper than 82.46% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of MELE to the average of the S&P500 Index (26.77), we can say MELE is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 16.12, the valuation of MELE can be described as correct.
Based on the Price/Forward Earnings ratio, MELE is valued cheaply inside the industry as 80.70% of the companies are valued more expensively.
MELE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.35.
Industry RankSector Rank
PE 21.38
Fwd PE 16.12
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MELE is valued a bit cheaper than the industry average as 77.19% of the companies are valued more expensively.
87.72% of the companies in the same industry are more expensive than MELE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.04
EV/EBITDA 12.47
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The decent profitability rating of MELE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.93
EPS Next 2Y-8.34%
EPS Next 3Y1.48%

4

5. Dividend

5.1 Amount

MELE has a Yearly Dividend Yield of 2.29%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 0.81, MELE pays a better dividend. On top of this MELE pays more dividend than 91.23% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, MELE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.29%

5.2 History

On average, the dividend of MELE grows each year by 10.98%, which is quite nice.
Dividend Growth(5Y)10.98%
Div Incr Years3
Div Non Decr Years6
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

112.64% of the earnings are spent on dividend by MELE. This is not a sustainable payout ratio.
MELE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP112.64%
EPS Next 2Y-8.34%
EPS Next 3Y1.48%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELEXIS NV

EBR:MELE (12/30/2025, 7:00:00 PM)

57.3

+0.45 (+0.79%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-04 2026-02-04/amc
Inst Owners15.31%
Inst Owner ChangeN/A
Ins Owners25%
Ins Owner ChangeN/A
Market Cap2.31B
Revenue(TTM)822.53M
Net Income(TTM)131.83M
Analysts75.79
Price Target72.18 (25.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.29%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP112.64%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.96%
Min EPS beat(2)-2.47%
Max EPS beat(2)42.38%
EPS beat(4)1
Avg EPS beat(4)-0.06%
Min EPS beat(4)-38.45%
Max EPS beat(4)42.38%
EPS beat(8)3
Avg EPS beat(8)-0.67%
EPS beat(12)6
Avg EPS beat(12)0.27%
EPS beat(16)10
Avg EPS beat(16)4.23%
Revenue beat(2)1
Avg Revenue beat(2)0.71%
Min Revenue beat(2)-1.87%
Max Revenue beat(2)3.28%
Revenue beat(4)1
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)3.28%
Revenue beat(8)1
Avg Revenue beat(8)-1.74%
Revenue beat(12)3
Avg Revenue beat(12)-1.22%
Revenue beat(16)6
Avg Revenue beat(16)-0.6%
PT rev (1m)-4.69%
PT rev (3m)-5.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.48%
EPS NY rev (1m)0.31%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE 21.38
Fwd PE 16.12
P/S 2.71
P/FCF 25.04
P/OCF 17.56
P/B 4.55
P/tB 4.57
EV/EBITDA 12.47
EPS(TTM)2.68
EY4.68%
EPS(NY)3.55
Fwd EY6.2%
FCF(TTM)2.29
FCFY3.99%
OCF(TTM)3.26
OCFY5.7%
SpS21.17
BVpS12.58
TBVpS12.55
PEG (NY)N/A
PEG (5Y)0.93
Graham Number27.54
Profitability
Industry RankSector Rank
ROA 14.2%
ROE 25.94%
ROCE 18.88%
ROIC 15.69%
ROICexc 16.36%
ROICexgc 16.39%
OM 18.29%
PM (TTM) 15.42%
GM 40.24%
FCFM 10.81%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
ROICexc(3y)38.83%
ROICexc(5y)36.08%
ROICexgc(3y)39.06%
ROICexgc(5y)36.42%
ROCE(3y)37.33%
ROCE(5y)34.27%
ROICexgc growth 3Y-14.81%
ROICexgc growth 5Y1.87%
ROICexc growth 3Y-14.47%
ROICexc growth 5Y2.21%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 3.48
Debt/EBITDA 1.52
Cap/Depr 77.5%
Cap/Sales 4.61%
Interest Coverage 14.77
Cash Conversion 63.61%
Profit Quality 70.12%
Current Ratio 5.59
Quick Ratio 2.71
Altman-Z 6.17
F-Score4
WACC11.01%
ROIC/WACC1.43
Cap/Depr(3y)136.47%
Cap/Depr(5y)110.04%
Cap/Sales(3y)6.76%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.51%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-46.03%
EPS Next Y-29.28%
EPS Next 2Y-8.34%
EPS Next 3Y1.48%
EPS Next 5Y7.41%
Revenue 1Y (TTM)-16.57%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-13.14%
Revenue Next Year-10.45%
Revenue Next 2Y-1.26%
Revenue Next 3Y2.16%
Revenue Next 5Y5.53%
EBIT growth 1Y-40.01%
EBIT growth 3Y13.74%
EBIT growth 5Y24.11%
EBIT Next Year-16.89%
EBIT Next 3Y5.62%
EBIT Next 5Y7.46%
FCF growth 1Y533.33%
FCF growth 3Y6.64%
FCF growth 5Y13.04%
OCF growth 1Y213.78%
OCF growth 3Y7.8%
OCF growth 5Y13.55%

MELEXIS NV / MELE.BR FAQ

What is the ChartMill fundamental rating of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MELE.BR.


What is the valuation status for MELE stock?

ChartMill assigns a valuation rating of 6 / 10 to MELEXIS NV (MELE.BR). This can be considered as Fairly Valued.


How profitable is MELEXIS NV (MELE.BR) stock?

MELEXIS NV (MELE.BR) has a profitability rating of 7 / 10.


What is the financial health of MELEXIS NV (MELE.BR) stock?

The financial health rating of MELEXIS NV (MELE.BR) is 6 / 10.


Can you provide the dividend sustainability for MELE stock?

The dividend rating of MELEXIS NV (MELE.BR) is 4 / 10 and the dividend payout ratio is 112.64%.